Skip to main content
UploadLanguage (EN)Support
BusinessMobileSocial MediaMarketingTechnologyArt & PhotosCareerDesignEducationPresentations & Public SpeakingGovernment & NonprofitHealthcareInternetLawLeadership & ManagementAutomotiveEngineeringSoftwareRecruiting & HRRetailSalesServicesScienceSmall Business & EntrepreneurshipFoodEnvironmentEconomy & FinanceData & AnalyticsInvestor RelationsSportsSpiritualNews & PoliticsTravelSelf ImprovementReal EstateEntertainment & HumorHealth & MedicineDevices & HardwareLifestyle
Uploaded byssuser13a3c4
PPTX, PDF129 views

Vaccines and Microbial Bioactive Products.pptx

The document provides an overview of vaccines and bioactive microbial products, highlighting their significance in public health, agriculture, and environmental sustainability. It details the immune system's role in vaccine development, types of vaccines, and their production processes. Additionally, it covers emerging trends in vaccine technology and challenges related to accessibility and antimicrobial resistance in bioactive compounds.

Education◦
Download to read offline
Vaccines and Microbial Bioactive Products
• Objective: Provide students with foundational knowledge and the significance of microbial products in industrial applications. • Overview: – Vaccines: Biological preparations designed to prevent specific diseases by inducing immunity. – Bioactive Microbial Products: Compounds derived from microbes that have beneficial biological effects, such as antibiotics, anticancer agents, and enzymes used in various industries. • Importance of Microbial Products: – Public Health: Vaccines prevent diseases and save lives. Antibiotics treat infections. – Agriculture: Biopesticides, biofertilizers, and growth-promoting substances reduce chemical dependency. – Environmental Sustainability: Biodegradable alternatives and bioremediation products help reduce environmental impacts. • Industrial Relevance: – Microbial products are key in pharmaceuticals, agriculture, food production, and other industries.
Basics of Immunology in Vaccine Development • Immune System Overview: • Innate Immunity: – This is the body’s first line of defense against pathogens and includes physical barriers (like skin and mucous membranes), cellular defenses (like macrophages, neutrophils, and natural killer cells), and signaling molecules (like cytokines and chemokines). – Innate immunity is rapid but non-specific, meaning it cannot recognize specific pathogens, only general signs of infection.
• Adaptive Immunity: – Adaptive immunity is slower to respond initially but is highly specific, targeting specific pathogens using T-cells and B-cells. – B-cells produce antibodies (humoral response) that bind to pathogens and mark them for destruction. – T-cells directly kill infected cells (cell-mediated response) or help regulate other immune cells. – Adaptive immunity includes memory cells, allowing the immune system to recognize and respond quickly upon re- exposure to the same pathogen.
• How Vaccines Work: – Vaccines stimulate the adaptive immune system by introducing an antigen that mimics a pathogen, prompting the production of specific antibodies and memory cells. – Primary Immune Response: Upon the first exposure to a pathogen or vaccine, the immune system takes time to recognize the antigen and produce antibodies. – Secondary Immune Response: With memory cells in place, a subsequent exposure results in a much faster and stronger immune response, preventing illness.
• Types of Immunity: – Active Immunity: Developed through infection or vaccination, leading to long-term protection by creating memory cells. – Passive Immunity: Obtained through the transfer of antibodies from another source (e.g., maternal antibodies, antibody therapies), which provides immediate, short-term protection without memory.
Types of Vaccines and Their Microbial Sources 1. Live Attenuated Vaccines: • Description: These vaccines use a weakened (attenuated) form of the pathogen that can still replicate but is not virulent enough to cause illness in healthy individuals. • Examples: Measles, Mumps, Rubella (MMR), and Varicella (Chickenpox) vaccines. • Production Process: – Live attenuated vaccines are produced by cultivating the pathogen in a way that reduces its ability to cause disease in humans. – Common techniques include culturing the pathogen in non-human cells or at low temperatures, which selects for strains that are adapted to these conditions but weakened in humans.
• Mechanism: Since the pathogen is still alive but attenuated, it replicates within the host, triggering a strong immune response that closely mimics natural infection. • Pros/Cons: – Pros: Provides robust, long-lasting immunity with often just one or two doses. – Cons: May not be safe for people with weakened immune systems; requires careful cold storage to maintain viability, which can limit distribution in low-resource areas.
2. Inactivated (Killed) Vaccines: • Description: Made from pathogens that have been killed or inactivated so they cannot replicate, but still retain their ability to stimulate an immune response. • Examples: Inactivated Polio Vaccine (IPV), Hepatitis A. • Production Process: – Pathogens are grown in suitable culture media and then killed using heat or chemicals, such as formaldehyde, ensuring they cannot cause disease.
• Mechanism: Inactivated pathogens are introduced to the immune system, prompting antibody production without the risk of infection. • Pros/Cons: – Pros: Safe for people with compromised immune systems as there is no risk of the pathogen reverting to a virulent form. – Cons: Often requires multiple doses to build and maintain immunity; does not replicate in the body, so it may elicit a weaker immune response than live vaccines.
3. Subunit, Recombinant, and Conjugate Vaccines: • Description: These vaccines use only parts of the pathogen, such as proteins, polysaccharides, or other molecules, rather than the entire organism. • Examples: Hepatitis B, HPV, and Pneumococcal vaccines. • Production Process: – Subunit vaccines involve isolating key antigens, such as surface proteins. Recombinant vaccines use genetic engineering to produce the antigen in a lab, often in yeast or bacterial cells. – Conjugate vaccines link (or “conjugate”) weak antigens, such as polysaccharides, to stronger carrier proteins to enhance immune response, especially in children.
• Mechanism: These vaccines target specific parts of the pathogen, reducing the likelihood of side effects while still providing a focused immune response. • Pros/Cons: – Pros: Highly targeted, lower risk of adverse reactions, can be safely given to immunocompromised individuals. – Cons: Often requires an adjuvant (substance that boosts the immune response) and booster shots to be fully effective.
4. mRNA Vaccines: • Description: A new technology that uses mRNA encoding a viral protein (like the spike protein of SARS- CoV-2) rather than the pathogen itself. • Examples: COVID-19 vaccines by Pfizer-BioNTech (Comirnaty) and Moderna (Spikevax). • Production Process: – Synthetic mRNA is created in the lab to instruct cells to produce the protein of interest. The mRNA is encapsulated in lipid nanoparticles to protect it and facilitate entry into cells.
• Mechanism: Once inside the cell, the mRNA is translated into the viral protein, which is presented on the cell surface, triggering an immune response. • Pros/Cons: – Pros: Rapid to develop and easy to adapt to new strains, as only the mRNA sequence needs to be changed. – Cons: Requires ultra-cold storage, making distribution challenging; higher production costs compared to traditional vaccines.
Vaccine Production Technology • Culturing Pathogens: – Pathogens for vaccines are grown in controlled environments using various bioreactors or cell cultures, depending on the microorganism. – Bacterial Vaccines: Typically grown in large fermenters; parameters like oxygen levels, temperature, and pH are optimized. – Viral Vaccines: Often require living cells for propagation. Some are grown in fertilized chicken eggs (e.g., influenza vaccine) or mammalian cell lines.
• Purification Techniques: – Filtration: Used to remove impurities from cultured pathogens. – Chromatography: Used to purify antigens; methods include affinity chromatography, which binds specific proteins, or ion-exchange chromatography. – Centrifugation: Separates particles by density, commonly used for viral vaccines.
• Adjuvants: – Substances that boost the immune response, allowing for smaller doses of the antigen. – Examples include aluminum salts (alum) and newer oil-in-water emulsions (MF59, AS03). – Adjuvants increase antigen uptake by dendritic cells and enhance memory cell production. • Stabilization and Storage: – Lyophilization (Freeze-Drying): Removes water to stabilize vaccines, extending shelf life. – Cold Chain Requirements: Ensures vaccines remain potent from manufacturing to administration; mRNA vaccines require very low temperatures. • Quality Control: – Rigorous testing is conducted to ensure vaccines are safe, potent, and effective. – Preclinical and clinical trials in phases (Phase I, II, and III) assess safety, optimal dosing, and efficacy.
Applications and Challenges in Vaccine Development • Emerging Infectious Diseases: – Rapid vaccine development for new diseases (e.g., COVID-19, Ebola) is critical. – New technologies like mRNA and vector-based vaccines allow faster response times than traditional methods. • Vaccine Accessibility: – Disparities in access due to distribution challenges, production costs, and cold chain requirements, especially in low-resource regions. – Organizations like COVAX aim to improve vaccine access globally. • Public Health and Ethical Considerations: – Addressing vaccine hesitancy, which can hinder public health efforts. – Transparent communication and public education are essential to combat misinformation. – Ethical considerations in mandatory vaccinations and balancing public health with individual choice.
Bioactive Compounds • Definition: Compounds from microorganisms with biological activity beneficial for humans, animals, and plants. • Types and Applications: – Antibiotics: Treat bacterial infections (e.g., penicillin, streptomycin). – Anticancer Agents: Inhibit cancer cell growth (e.g., doxorubicin, bleomycin). – Antivirals: Target viral infections (e.g., acyclovir, zanamivir). – Immunosuppressants: Control immune responses, especially in transplants (e.g., cyclosporine). – Agriculture and Industry: Biopesticides, biofertilizers, and enzymes.
Sources of Bioactive Microbial Products • Bacteria: – Actinobacteria: Known for producing antibiotics like streptomycin, erythromycin. – Myxobacteria: Source of lipopeptide antibiotics. • Fungi: – Penicillium: Penicillin and other beta-lactam antibiotics. – Aspergillus: Aflatoxins, used in enzyme production. • Marine Microbes: – Unique environments lead to unique bioactive molecules, e.g., marine actinomycetes, cyanobacteria. • Metagenomic Approaches: – Analyzing microbial communities directly from the environment for novel gene clusters that could encode bioactive compounds.
Production and Downstream Processing • Fermentation Technology: – Batch, Fed-Batch, Continuous Cultures: Different modes of fermentation based on microbial growth characteristics. – Optimization: Adjusting pH, temperature, oxygen, and nutrients for maximum yield. • Downstream Processing: – Cell Disruption: Mechanical, chemical, or enzymatic methods to release products. – Purification: Uses chromatography, solvent extraction, and drying techniques.
Screening and Optimization for Bioactive Compounds • Screening: – Bioassays: Testing crude extracts on target cells or enzymes. – High-Throughput Screening: Enables rapid testing of large numbers of samples. • Strain Improvement: – Mutagenesis: Inducing random mutations to increase yield. – Genetic Engineering: Using CRISPR or plasmid insertion to improve strain productivity. • Optimization: – Response Surface Methodology (RSM): Statistical method to find optimal growth conditions.
Applications and Challenges of Bioactive Microbial Products • Medical Uses: – Treatments for bacterial infections, cancers, and viral diseases. • Agricultural Uses: – Biopesticides: Natural alternatives to chemical pesticides (e.g., Bacillus thuringiensis). – Biofertilizers: Promote plant growth, reduce chemical fertilizer use. • Challenges: – Antimicrobial Resistance: Limits effectiveness of antibiotics, requiring regulatory hurdles, and high production costs
Conclusion and Future Trends • Emerging Trends in Vaccine Technology: – Personalized vaccines, synthetic biology, and DNA vaccines. • Future Directions for Bioactive Compounds: – Genome mining, synthetic biology to create new bioactives. • Ethical and Sustainability Considerations: – Ensuring equitable access to vaccines and bioactive compounds, environmental impact of microbial resource utilization.